Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


European Pharmaceutical Pricing & Reinbursement

29 Oct 2012 - 30 Oct 2012 - London, UK



Bookmark and Share


SMi are proud to present their 18th annual market leading European Pharmaceutical Pricing and Reimbursement conference. This year’s event will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as market access strategies, recent developments in the healthcare landscape and challenges in VBP and AMNOG. As well as exclusive presentations on the latest P&R developments across Europe and further afield, the event will act as a unique forum for attendees to learn, make connections and explore new ideas.

Key benefits of attending:

Hear from experts in the field on Value Based Pricing: Principles and practice

Debate EU policy challenges in access to medicines in Europe with experts from Germany, Italy, UK, Switzerland and Belgium

Analyse market access in Russia, Turkey and Eastern Europe

Learn about the latest regulations within pricing and reimbursement from industry

Understand the facts and consequences of Germany’s AMNOG

Discover the value of collaboration in HTA and managed entry schemes

Consider an international view with perspectives from the Asia-Pac Region and North America

Network with and learn from senior industry representatives from companies such as Sanofi, GSK, Abbott & UCB 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012europricing26.asp



Further information
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
Novel Urine Test to Predict High-Risk Cervical Cancer
Preliminary studies affirm accuracy and potential cost savings to screen for virus-caused malignancy.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!